中国现代神经疾病杂志 ›› 2015, Vol. 15 ›› Issue (8): 638-644. doi: 10.3969/j.issn.1672-6731.2015.08.007

• 痴呆及相关认知功能障碍 • 上一篇    下一篇

2 血清胱抑素C 对初诊帕金森病患者轻度认知损害的早期诊断价值

马灿灿, 陈蓓蕾, 徐俊, 陈兰兰, 徐耀, 袁成林, 张熙斌, 张洪英, 吴晶涛, 周林   

  1. 225001 扬州,江苏省苏北人民医院神经内科(马灿灿、陈蓓蕾、徐俊、陈兰兰、徐耀、袁成林),康复中心(张熙斌),医学影像科(张洪英、吴晶涛),医学检验科(周林)
  • 出版日期:2015-08-25 发布日期:2015-08-13
  • 通讯作者: 徐俊(Email:13611572068@126.com)
  • 基金资助:

    科技部“重大新药创制”重大专项项目(项目编号:2012ZX09303-003);科技部“重大新药创制”重大专项项目(项目编号:2012ZX09303005-002);国家自然科学基金资助项目(项目编号:81471215);国家自然科学基金资助项目(项目编号:81271211);国家自然科学基金资助项目(项目编号:30700248);江苏省科技支撑计划项目(项目编号:BE2011614);江苏省重点实验室开放课题(项目编号:SJ11KF05);江苏省“333 高层次人才培养工程”资助项目[项目编号:(2013)Ⅲ-0077 号];江苏省“六大人才高峰”资助项目(项目编号:2012-WS-002);江苏省扬州市“绿扬金凤计划”创新领军人才项目(项目编号:yzlyjfjh2013CX056)

Diagnostic value of serum cystatin C on newly diagnosed Parkinson's disease with mild cognitive impairment

MA Can-can1, CHEN Bei-lei1, XU Jun1, CHEN Lan-lan1, XU Yao1, YUAN Cheng-lin1, ZHANG Xi-bin2, ZHANG Hong-ying3, WU Jing-tao3, ZHOU Lin4   

  1. 1Department of Neurology, 2Rehabilitation Center, 3Department of Radiology, 4Department of Laboratory Medicine, Northern Jiangsu People's Hospital, Yangzhou 225001, Jiangsu, China
  • Online:2015-08-25 Published:2015-08-13
  • Contact: XU Jun (Email: 13611572068@126.com)
  • Supported by:

    This study was supported by "Major New Drugs Innovation and Development" Project of Ministry of Science and Technology (No. 2012ZX09303-003, 2012ZX09303005-002), National Natural Science Foundation of China (No. 81471215, 81271211, 30700248), Science and Technology Support Project of Jiangsu Province (No. BE2011614), Open Project of Key Laboratory of Jiangsu Province (No. SJ11KF05), Jiangsu Province "333 High-Level Talents" Third Level [No. (2013) Ⅲ -0077], "Six Peaks of Talents" Support Program of Jiangsu Province (No. 2012-WS-002) and "Lü Yang Jin Feng" Innovation Leading Personnel (No. yzlyjfjh2013CX056).

摘要:

目的 探讨血清胱抑素C(Cys-C)表达变化对初诊帕金森病患者轻度认知损害的早期诊断价值。方法 共101 例初诊帕金森病患者分为帕金森病轻度认知损害组(PD-MCI组,43 例)和帕金森病认知功能正常组(对照组,58 例),循环酶法检测血清Cys-C、脂质、肌酐和尿酸水平,简易智能状态检查量表(MMSE)和蒙特利尔认知评价量表(MoCA)评价认知功能;Logistic 回归分析评价血清Cys-C 与认知功能间的相关性;受试者工作特征曲线(ROC 曲线)计算血清Cys-C 早期诊断帕金森病轻度认知损害之灵敏度、特异度和准确率。结果 PD-MCI 组患者血清Cys-C 水平高于对照组[(1.12 ± 0.10)mg/L 对(1.00 ± 0.15)mg/L,P = 0.000]。各项危险因素筛查仅血清Cys-C 为帕金森病患者轻度认知损害的独立危险因素(OR = 4.285,95%CI:1.301 ~ 14.112;P = 0.017),且与MMSE 总评分(rs = -0.831,P = 0.000)和MoCA总评分(rs = -0.848, = 0.000),以及视空间能力和执行功能(rs = -0.495, = 0.001)、注意力和计算力(rs = -0.339, = 0.026)、延迟回忆(rs = -0.307,P = 0.045)评分均呈负相关;ROC 曲线下面积为0.707(95%CI:0.603 ~ 0.811, = 0.000),诊断灵敏度和特异度分别为53.50%和82.80%,所对应的血清Cys-C 临界值为1.105 mg/L。结论 血清Cys-C 表达水平升高可能与初诊帕金森病患者轻度认知损害密切相关,具有早期诊断参考价值。

关键词: 半胱氨酸蛋白酶抑制剂, 帕金森病, 认知障碍, 危险因素, 回归分析

Abstract:

Objective  To investigate the diagnostic value of expression level of serum cystatin C (Cys-C) on early diagnosis of newly diagnosed Parkinson's disease with mild cognitive impairment (PD-MCI).  Methods  A total of 101 PD patients were divided into 2 groups: PD-MCI gruop (N = 43) and PD with normal cognition group (control group, N = 58). The levels of serum Cys-C, lipid, creatinine (Cr) and uric acid (UA) were tested. Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) were used to evaluate cognitive function, and Logistic regression analysis was used to evaluate the correlation between PD-MCI and the level of serum Cys-C. Receiver operating characteristic (ROC) curve was used to detect the sensitivity and specificity of early diagnosis.  Results  The expression level of serum Cys-C in PD-MCI group [(1.12 ± 0.10) mg/L] was higher than that of control group [(1.00 ± 0.15) mg/L, P = 0.000]. Univariate and multivariate Logistic regression analysis showed that serum Cys-C was the independent risk factor for PD-MCI (OR = 4.285, 95% CI: 1.301-14.112; P = 0.017); Spearman rank correlation analysis showed the expression level of serum Cys-C was negatively correlated with MMSE total score (rs = -0.831, P = 0.000), MoCA total score (rs = -0.848, P = 0.000), visuospatial/executive function (rs = -0.495, P = 0.001), attention/counting (rs = -0.339, P = 0.026) and delayed recall (rs = -0.307, P = 0.045). ROC curve analysis showed that area under the curve (AUC) was 0.707 (95%CI: 0.603-0.811, P = 0.000). Diagnostic sensitivity and specificity were 53.50% and 82.80% respectively, and the critical value of serum Cys-C level was 1.105 mg/L.  Conclusions  Increased expression level of serum Cys-C maybe closely related with newly diagnosed PD-MCI, and has a certain value to the early diagnosis of PD-MCI.

Key words: Cysteine proteinase inhibitors, Parkinson disease, Cognition disorders, Risk factors, Regression analysis